openPR Logo
Press release

Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 - Pipeline Review: Share, Growth, Trends and Forecast 2017 – 2022

06-20-2017 04:50 PM CET | Health & Medicine

Press release from: Medical Industry Research Reports-[MRH]

Market Research Hub

Market Research Hub

“Ectonucleotide Pyrophosphatas Family” Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (ENPP2) is an enzyme encoded by the ENPP2 gene. It stimulates migration of melanoma cells. It has a role in induction of parturition. It is involved in cell proliferation and adipose tissue development.

Request For Free Sample @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1157728

Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) pipeline Target constitutes close to 11 molecules. Out of which approximately 8 molecules are developed by companies and remaining by the universities/institutes. The molecules developed by companies in Phase II and Preclinical stages are 1 and 7 respectively. Similarly, the universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively. Report covers products from therapy areas Oncology, Gastrointestinal, Respiratory, Central Nervous System, Immunology, Musculoskeletal Disorders, Cardiovascular, Genito Urinary System And Sex Hormones and Male Health which include indications Idiopathic Pulmonary Fibrosis, Breast Cancer, Fibrosis, Liver Fibrosis, Lung Cancer, Multiple Sclerosis, Systemic Sclerosis (Scleroderma), Acute Pain, Atherosclerosis, Benign Prostatic Hyperplasia, Brain Ischemia, Chronic Obstructive Pulmonary Disease (COPD), Chronic Pain, Inflammatory Bowel Disease, Melanoma, Metastatic Lung Cancer, Musculoskeletal Pain, Non-Alcoholic Steatohepatitis (NASH), Osteoarthritis Pain, Ovarian Cancer, Thyroid Cancer and Visceral Pain.

The latest report Ectonucleotide PyrophosphatasePhosphodiesterase Family Member 2 - Pipeline Review, H1 2017, outlays comprehensive information on the Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews key players involved in Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics development with respective active and dormant or discontinued projects.

The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape for Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39)
- The report reviews Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics and enlists all their major and minor projects
- The report assesses Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) targeted therapeutics

Browse Full Report With TOC @ http://www.marketresearchhub.com/report/ectonucleotide-pyrophosphatasephosphodiesterase-family-member-2-autotaxin-or-extracellular-lysophospholipase-d-or-enpp2-or-ec-31439-pipeline-review-h1-2017-report.html

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Overview
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Products under Development by Universities/Institutes
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 (Autotaxin or Extracellular Lysophospholipase D or ENPP2 or EC 3.1.4.39) - Companies Involved in Therapeutics Development
Eli Lilly and Company
Continue….

Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1157728

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:

90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read More Related News: https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ectonucleotide Pyrophosphatase/Phosphodiesterase Family Member 2 - Pipeline Review: Share, Growth, Trends and Forecast 2017 – 2022 here

News-ID: 587686 • Views:

More Releases from Medical Industry Research Reports-[MRH]

Global Ophthalmic Diagnostic Devices Sales Market Report : Share, Growth, Size, Trends and Forecast 2017 - 2022
Global Ophthalmic Diagnostic Devices Sales Market Report : Share, Growth, Size, …
Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global Ophthalmic Diagnostic Devices Sales Market Report” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions. Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1324423 Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million
United States Negative Pressure Wound Therapy (NPWT) Market Projections & Upcoming Trends Recorded till 2024
United States Negative Pressure Wound Therapy (NPWT) Market Projections & Upcomi …
 This report on the United States negative pressure wound therapy (NPWT) market is filled with necessary details and facts which provide deep insight into this sector. Further, extensive interviews are conducted with chief opinion leaders (KOLs), physicians and industry experts to authenticate the market size, company share as well as distribution share data and analysis. The report titled “United States Negative Pressure Wound Therapy (NPWT) Market Outlook to 2024”, has been
Global Intraoperative Ultrasound Market, Growth, Analysis, Production, Forecasts Research Report to 2017
Global Intraoperative Ultrasound Market, Growth, Analysis, Production, Forecasts …
To Understand the medical equipments Industry Status worldwide, Market Research Hub (MRH) has included the latest Forecast report titled “Global Intraoperative Ultrasound Market Reports September, 2017” to its vast database. This study offers data about the prime regions operating in the medical equipments sector, along with their production, consumption, revenue and market share details. Further, the intelligent report also anticipates that the market would grow at a constructive CAGR until
Global RFID Medical Inventory Management Systems Market Research Report Share, Growth, Size, Trends and Forecast 2017 - 2022
Global RFID Medical Inventory Management Systems Market Research Report Share, G …
Market Research Hub (MRH) has recently added a new report to its vast online database. This research study is titled as “Global RFID Medical Inventory Management Systems Market Report” 2017 which presents an in-depth study about the production, consumption, market volume, revenue (million USD) and market share across different geographical regions. Request For Free Sample - http://www.marketresearchhub.com/enquiry.php?type=S&repid=1313969 Geographically, this report is segmented into several key Regions, with production,

All 5 Releases


More Releases for Ectonucleotide

Coking Benzene Market Outlook 2031 Data By Key Players-Sigma-Aldrich, Alfa Aesar …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to 𝐌𝐑𝐈, the global Coking Benzene Market size in terms of revenue was valued at around USD XX.X billion in 2023 and is expected to reach a value of 𝐔𝐒𝐃 𝐗𝐗.𝐗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏, growing at a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝐫𝐨𝐮𝐠𝐡𝐥𝐲 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏. The global Coking Benzene market is projected to grow at a significant growth rate due to several driving factors. The market for coking benzoene is expanding significantly, mostly
Acrylate-Butadiene Rubber Market Outlook 2031 Analysis By Key Players-LANXESS AG …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to 𝐌𝐑𝐈, the global Acrylate-Butadiene Rubber Market size in terms of revenue was valued at around USD XX.X billion in 2023 and is expected to reach a value of 𝐔𝐒𝐃 𝐗𝐗.𝐗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏, growing at a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝐫𝐨𝐮𝐠𝐡𝐥𝐲 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏. The global Acrylate-Butadiene Rubber market is projected to grow at a significant growth rate due to several driving factors. The growing need for Acrylate-Butadiene Rubber (ABR) in the
2,3-Diaminopyridine Market Outlook 2031 Report By Key Players-Sigma-Aldrich, Alf …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to 𝐌𝐑𝐈, the global 2,3-Diaminopyridine Market size in terms of revenue was valued at around USD XX.X billion in 2023 and is expected to reach a value of 𝐔𝐒𝐃 𝐗𝐗.𝐗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏, growing at a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝐫𝐨𝐮𝐠𝐡𝐥𝐲 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏. The global 2,3-Diaminopyridine market is projected to grow at a significant growth rate due to several driving factors. The market for 2,3-diaminopyridine is expanding significantly due to its growing
Wooden Packaging Boxes Market Outlook 2031 Findings By Key Players-CHEP, PGS Gro …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to 𝐌𝐑𝐈, the global Wooden Packaging Boxes Market size in terms of revenue was valued at around USD XX.X billion in 2023 and is expected to reach a value of 𝐔𝐒𝐃 𝐗𝐗.𝐗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏, growing at a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝐫𝐨𝐮𝐠𝐡𝐥𝐲 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏. The global Wooden Packaging Boxes market is projected to grow at a significant growth rate due to several driving factors. The market for wooden packaging boxes is
B2B Concentrated Fruit Juice Market Outlook 2031 Overview By Key Players-Diana F …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to 𝐌𝐑𝐈, the global B2B Concentrated Fruit Juice Market size in terms of revenue was valued at around USD XX.X billion in 2023 and is expected to reach a value of 𝐔𝐒𝐃 𝐗𝐗.𝐗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏, growing at a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝐫𝐨𝐮𝐠𝐡𝐥𝐲 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏. The global B2B Concentrated Fruit Juice market is projected to grow at a significant growth rate due to several driving factors. The B2B concentrated fruit juice
Magnetic Core Materials Market Outlook 2031 Statistics By Key Players-Hitachi Me …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to 𝐌𝐑𝐈, the global Magnetic Core Materials Market size in terms of revenue was valued at around USD XX.X billion in 2023 and is expected to reach a value of 𝐔𝐒𝐃 𝐗𝐗.𝐗 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏, growing at a 𝐂𝐀𝐆𝐑 𝐨𝐟 𝐫𝐨𝐮𝐠𝐡𝐥𝐲 𝐗𝐗.𝐗% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟒 𝐭𝐨 𝟐𝟎𝟑𝟏. The global Magnetic Core Materials market is projected to grow at a significant growth rate due to several driving factors. The